Post Tagged with: "CTT"

Statin wars: New episode. The Empire Strikes back

1 by / on 5 Oct 2014, / in statins

If you aren’t confused about what is going on with statins then you haven’t been paying attention. As an example of just how convoluted it’s getting, take the email forwarded to me last week that had gone to members of the British Cardiovascular Society (BCS) asking them to fill in a short survey about any patients who had stopped taking statins… (Read More…)

Statin flash: 10 reasons to say no + statistical fiddling spotted

10 by / on 14 Sep 2014, / in statins

Arriving at the debate on statins run by the Guild of Health Writers last week , I was very amused to discover that the redoubtable Professor Sir Rory Collins, arch champion of statins for-all and hammer of the BMJ, had declined to appear when told that indefatigable statin critic Dr Malcolm Kendrick, was speaking . Perhaps he’s realised his style of steamrollering critics is a PR disaster. … (Read More…)

Five worrying questions about statins

12 by / on 18 Jul 2014, / in statins

So several million more people are going to be prescribed statins but the vigorous campaign to inject some sanity into statin use has bought into sharp focus the conflict of interests at the heart of our health system.

One is whether the risks of these drugs when taken by healthy people actually outweigh the benefit? What we do know is that the only data on this comes from the manufacturers themselves. Think banks being the sole source of information about payment protection insurance or relying entirely on energy company data to choose the best tariff. (Read More…)

The statins wars: Another round and maybe some clarity

7 by / on 11 Jun 2014, / in statins

Don’t prescribe statins to any more people. That’s the clear message from a strongly worded open letter to the head of NICE and to the Health Secretary Jeremy Hunt published today. If you groan at the prospect of yet more confusion over statins, this post might bring a bit of clarity. Please read on.

It’s the latest volley in long running battle about whether cholesterol lowering statins are a good way of cutting the risk of heart attack and death in virtually the entire population with vanishingly small number of effects or whether they don’t actually benefit most people and are quite likely to cause side effects that range from the unpleasant to the deadly.(Read more…)

Eminence based medicine defends the status quo on statins

28 by / on 22 May 2014, / in statins

Last week I was called by a friend who opened the conversation by saying: “So you were wrong about statins.” He was referring to the correction that the British Medical Journal (BMJ) has had to make in two papers that claimed statins have a high level of side effects. But I certainly haven’t recanted and started popping those pills.
Given the huge amount of attention this has attracted, the actual point being “corrected” is remarkably small. It is the kind of thing that would normally be dealt with by publishing a response to the article in the journal. I’ll come to the specifics in a moment but first a bit of context…. (Read more…)

SOS: Sanity over Statins – CTT the house of statin secrets

8 by / on 4 Mar 2014, / in statins

Should a professional body, however eminent, be allowed to keep information about the safety of products they are supplying to public hidden so no one else can run tests on them? (Read more…)

SOS: Sanity over Statins – Sssssh Side effects, pharma’s fingers and a cunning plan

0 by / on 4 Mar 2014, / in statins

HealthInsightUK has a number of contributors who are experts in statins. Here three of them – Dr John Briffa, Zoë Harcombe and Aidan Goggins respond to the CTT investigation. They explain why side-effect data is unreliable and disagree about whether it is in the drug companies interest that the risk of side-effects is downplayed or is that part of cunning plan? (Read more…)

Statin trials: exaggerating benefits and ignoring the harm

1 by / on 30 Oct 2013, / in statins

The ‘Cochrane Collaboration’ is an international collective of researchers whose self-proclaimed role is to provide accurate and robust appraisals of health interventions. The group specialises in ‘meta-analyses’: the grouping together of several similar studies on interventions including drug therapies…

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann